The EU health minister failed to reach consensus on general guidelines for the use of AstraZeneca against Covida 19 on Wednesday, despite calling for coordination among member states to eliminate public distrust of the vaccine.
Soon after the European Medicines Agency (EMA) changed its guidelines on AstraZeneca, ministers held a special virtual meeting because it found that it may be related to very rare cases of abnormal blood clots. Nevertheless, EMA emphasizes that the benefits of vaccines still outweigh the risks.
Prior to the meeting, according to Reuters, the ministers currently chairing the Council of the European Union sent a letter to the ministers urging them to seek a common language on the use of vaccines.
However, the ministers did not reach a consensus at the meeting and kept different guidelines.
An EU official said that the talks will continue in future meetings.
Portugal warned in a letter to the minister on Tuesday: “We hope that the EMA data will not only directly affect the national vaccination plan, but also affect our citizens’ confidence in the covid-19 vaccine.”
The EU is responding to the slow implementation of vaccination due to supply issues and changes in AstraZeneca’s usage data, which has raised suspicions about the vaccine.
The Portuguese letter added: “Coordination at the EU level will be the key to stopping the spread of misinformation.”
Union Health Commissioner Stella Kyriakidds told the ministers at the meeting: “It is vital that we adopt a coordinated European approach, not to confuse citizens, and not to cause people to take the vaccine. Doubts.”
European Union countries recommend different age limits for AstraZeneca vaccination, although the EMA does not recommend any age limits due to lack of data to prove this.
Germany has banned the use of AstraZeneca by people over 60 and high-priority groups. The National Vaccine Board recommends that people under 60 who have received the first dose of AstraZeneca should receive another vaccine.
France and Belgium stated that AstraZeneca should only be provided to people over 55.
In Finland, it is only available to people over 65.
Italy on Wednesday recommended that AstraZeneca vaccine be given to people over 60 years old.
Currently, other EU countries have no restrictions on AstraZeneca vaccines.